LVAD therapy improves MR and tricuspid regurgitation severity



In patients undergoing left ventricular assist device (LVAD) therapy, the reported prevalence of moderate or severe mitral regurgitation (MR) varies widely between 18% and 77%

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our